KalVista

KALV

KALV KalVista NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    KALV Chart
    See on advanced chart >

    About

    Kalvista Pharmaceuticals, Inc.was incorporated in the state of Delaware on March 26, 2004. The company is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases...
    • Highlight
      A developer of protease inhibitors for the treatment of hereditary angioedema, and diabetic macular edema
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      04/09/2015
    • Established Date
      03/26/2004
    • Full-time Employees
      118
    • Address
      55 Cambridge Parkway Suite 901 East Cambridge Massachusetts 02142
    • Tel
      1-857-9990075
    • Website
    • Fiscal Year End Date
      04/30
    • Security Type
      Common Stock